Divalproex Sodium Tablet, Extended Release
Product Images NDC 68180-260
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68180-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)
Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)
Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)
Image 5 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 05)
Image 6 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 06)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.